Foster, T. P., Bruggeman, B. S., & Haller, M. J. (2025). Emerging Immunotherapies for Disease Modification of Type 1 Diabetes: Emerging Immunotherapies for Disease Modification of T1DM: T. P. Foster et al. Drugs, 85(4), 457-473. https://doi.org/10.1007/s40265-025-02150-8
Chicago Style (17th ed.) CitationFoster, Timothy P., Brittany S. Bruggeman, and Michael J. Haller. "Emerging Immunotherapies for Disease Modification of Type 1 Diabetes: Emerging Immunotherapies for Disease Modification of T1DM: T. P. Foster Et Al." Drugs 85, no. 4 (2025): 457-473. https://doi.org/10.1007/s40265-025-02150-8.
MLA (8th ed.) CitationFoster, Timothy P., et al. "Emerging Immunotherapies for Disease Modification of Type 1 Diabetes: Emerging Immunotherapies for Disease Modification of T1DM: T. P. Foster Et Al." Drugs, vol. 85, no. 4, 2025, pp. 457-473, https://doi.org/10.1007/s40265-025-02150-8.
Visit our Citation Styles guide for help on properly citing sources.